Search results for "EFFICACY"

showing 10 items of 588 documents

Mongersen, an oral SMAD7 antisense oligonucleotide, and crohn's disease

2015

Crohn's disease-related inflammation is characterized by reduced activity of the immunosuppressive cytokine transforming growth factor β1 (TGF-β1) due to high levels of SMAD7, an inhibitor of TGF-β1 signaling. Preclinical studies and a phase 1 study have shown that an oral SMAD7 antisense oligonucleotide, mongersen, targets ileal and colonic SMAD7.In a double-blind, placebo-controlled, phase 2 trial, we evaluated the efficacy of mongersen for the treatment of persons with active Crohn's disease. Patients were randomly assigned to receive 10, 40, or 160 mg of mongersen or placebo per day for 2 weeks. The primary outcomes were clinical remission at day 15, defined as a Crohn's Disease Activit…

MaleSMAD7 antisense oligonucleotidemedicine.medical_treatmentOligonucleotidesPharmacologyPLACEBO-CONTROLLED TRIALTHERAPYGastroenterologylaw.inventionACTIVATIONImmunosuppressive AgentGlucocorticoidRandomized controlled trialCrohn DiseaselawOligonucleotideMedicineYoung adultCrohn's diseaseSettore MED/12 - GastroenterologiabiologyINDUCTIONMedicine (all)Remission InductionGeneral MedicineMiddle AgedCrohn's diseaseCytokineC-Reactive ProteinCombinationDrug Therapy CombinationFemaleDrugImmunosuppressive AgentsCOLITISHumanAdultmedicine.medical_specialtyAdolescentINFLAMMATORY-BOWEL-DISEASE PLACEBO-CONTROLLED TRIAL NECROSIS-FACTOR-ALPHA TGF-BETA-1-MEDIATED SUPPRESSION COLITIS INDUCTION ACTIVATION EFFICACY THERAPY MICEPlaceboSmad7 ProteinDose-Response RelationshipYoung AdultPharmacotherapyDouble-Blind MethodDrug TherapyInternal medicineHumansAntisenseGlucocorticoidsAgedDose-Response Relationship Drugbusiness.industryC-reactive proteinNECROSIS-FACTOR-ALPHAOligonucleotides AntisenseTGF-BETA-1-MEDIATED SUPPRESSIONEFFICACYmedicine.diseaseClinical trialMICEbiology.proteinbusinessAdolescent; Adult; Aged; C-Reactive Protein; Crohn Disease; Dose-Response Relationship Drug; Double-Blind Method; Drug Therapy Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Oligonucleotides; Oligonucleotides Antisense; Remission Induction; Smad7 Protein; Young Adult; Medicine (all)INFLAMMATORY-BOWEL-DISEASE
researchProduct

Associations between self-efficacy, bullying and health-related quality of life in a school sample of adolescents: a cross-sectional study

2018

Background To better understand health-related quality of life (HRQOL) in adolescents, it is important to gain knowledge about factors associated with HRQOL. Being involved in bullying is a significant threat to health, and social and psychological well-being; further, such problems can last into adulthood. The aim of this study was to explore the role of general self-efficacy (GSE) and bullying in relation to HRQOL. We specifically sought to study the prevalence of bullying, as well as the associations between both bullying and self-efficacy and HRQOL in a sample of adolescents. Methods This was a cross-sectional study of 723 adolescents (12–18 years) attending schools selected using rando…

MaleSelf-efficaciesmedicine.medical_specialtyAdolescentCross-sectional studyHealth-related quality of life030209 endocrinology & metabolismAdolescentsHealth related life qualities03 medical and health sciences0302 clinical medicineQuality of lifeSurveys and QuestionnairesIntervention (counseling)EpidemiologyPrevalenceHumansMedicine030212 general & internal medicineChildLife qualitiesSelf-efficacySchoolsNorwaybusiness.industrylcsh:Public aspects of medicinePublic healthPublic Health Environmental and Occupational HealthBullyinglcsh:RA1-1270Self EfficacyhumanitiesPeer reviewSelf efficacyCross-Sectional StudiesVDP::Medisinske Fag: 700::Helsefag: 800HealthQuality of LifeFemaleBiostatisticsSelf-efficacybusinessResearch ArticleClinical psychologyBMC Public Health
researchProduct

Use of Robotics kits for the Enhancement of Metacognitive Skills of Mathematics: a Possible Approach.

2011

The present study is aimed at analyzing the process of building and programming robots as a metacognitive tool of mathematics. Quantitative data from a study performed on a sample of students attending an Italian secondary school are described. Results showed that robotics activities may be used as a new metacognitive environment allowing students to improve their attitude towards mathematics, and to increase their attitude to reflect on themselves and on their own learning, and their higher-level control components, such as forecasting, planning, monitoring and evaluation exercises and problems related to implementation.

MaleSettore M-PSI/01 - Psicologia GeneraleSettore M-PSI/04 - Psicologia Dello Sviluppo E Psicologia Dell'EducazioneCognitionAttitudeeducational robotics metacognition learning new technologyHumansFemaleRoboticsChildMathematicsSelf Efficacy
researchProduct

Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabet…

2016

Introduction: Combination therapy is needed to control blood pressure (BP) in a large number of hypertensive patients with diabetes mellitus. Adherence to treatment is a major clinical problem; therefore, the time duration of the antihypertensive action of a drug determines BP control when a dose is skipped. Objectives: The aim was to determine whether the fixed-dose combination of olmesartan/amlodipine provides equal efficacy and safety as the perindopril/amlodipine combination when a drug dose is missed. Methods: In this noninferiority trial with a randomized, double-blind, double-dummy parallel group, controlled design, 260 patients received either olmesartan 20-40 mg/amlodipine 5-10 mg …

MaleSettore MED/09 - Medicina InternaAntihypertensive agentsPhysiologyMissed DoseTetrazolesAngiotensin-Converting Enzyme InhibitorsBlood Pressure030204 cardiovascular system & hematologyPharmacologyEssential hypertensionlaw.invention0302 clinical medicineDiabetes mellitusRandomized controlled triallawAngiotensin II Type 1 Receptor BlockerDrug CombinationPerindoprilMedicine030212 general & internal medicineAntihypertensive agentTetrazoleImidazolesSettore MED/37 - NeuroradiologiaMiddle AgedCalcium Channel BlockersDrug CombinationsTreatment OutcomeHypertensionFemaleEssential HypertensionOlmesartanCalcium Channel BlockerCardiology and Cardiovascular MedicineType 2circulatory and respiratory physiologymedicine.drugHumanAdultmedicine.medical_specialtyAmlodipine; Antihypertensive agents; Blood pressure; Diabetes mellitus; Olmesartan; Perindopril; Internal Medicine; Physiology; Cardiology and Cardiovascular MedicineDiabetes mellitumissed dose; hypertension; therapeutic efficacyCombination therapyUrologytherapeutic efficacyNOMedication Adherence03 medical and health sciencesDouble-Blind MethodInternal MedicineHumansOlmesartanAmlodipineamlodipine antihypertensive agents blood pressure diabetes mellitus olmesartan perindoprilImidazolemissed doseAgedbusiness.industryAngiotensin-Converting Enzyme Inhibitormedicine.diseaseAmlodipine; Antihypertensive agents; Blood pressure; Diabetes mellitus; Olmesartan; Perindopril; Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus Type 2; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Imidazoles; Male; Medication Adherence; Middle Aged; Perindopril; Tetrazoles; Treatment Outcome; Internal Medicine; Physiology; Cardiology and Cardiovascular MedicineBlood pressureDiabetes Mellitus Type 2PerindoprilAmlodipinebusinessAngiotensin II Type 1 Receptor Blockers
researchProduct

Application of the Health Action Process Approach to Social Distancing Behavior During COVID‐19

2020

Author(s): Hamilton, Kyra; Smith, Stephanie R; Keech, Jacob J; Moyers, Susette A; Hagger, Martin S | Abstract: BackgroundThis study examined the social cognition determinants of social distancing behavior during the COVID-19 pandemic in samples from Australia and the US guided by the health action process approach (HAPA).MethodsParticipants (Australia: Nn=n495, 50.1% women; US: Nn=n701, 48.9% women) completed HAPA social cognition constructs at an initial time-point (T1), and one week later (T2) self-reported their social distancing behavior.ResultsSingle-indicator structural equation models that excluded and included past behavior exhibited adequate fit with the data. Intention and action …

MaleSocial CognitionHealth Behavior050109 social psychologypandemiatModelsAdaptation PsychologicalPsychologycoping planningProspective StudiesApplied Psychologymedia_commonSocial distance05 social sciencesMiddle AgedSelf Efficacyhealth action process approachdual‐phase modelFemaleOriginal Article0305 other medical sciencePsychologyself-efficacySocial psychologyself‐efficacyAdultmedia_common.quotation_subjectPhysical DistancingSample (statistics)social cognitionModels PsychologicalomatoimisuusStructural equation modeling03 medical and health sciencesetäisyysSocial cognitionPerceptionHumansaction planning0501 psychology and cognitive sciencesAdaptationphysical distancingAgedSelf-efficacy030505 public healthintentioHealth action process approachsosiaalinen kognitioAustraliaCOVID-19Original ArticlesUnited Stateshealth action process approach [dual‐phase model]Action (philosophy)terveyskäyttäytyminenPsychologicaldual-phase modelApplied Psychology: Health and Well-Being
researchProduct

Psychological correlates of physical activity and exercise preferences in metropolitan and nonmetropolitan cancer survivors.

2020

OBJECTIVE: Interventions to increase physical activity (PA) in cancer survivors have often adopted a 'one-size-fits-all' approach, and may benefit from being tailored to psychological constructs associated with behavior. The study objective was to investigate the exercise preferences and psychological constructs related to PA among cancer survivors. METHODS: Post-treatment colorectal, endometrial, and breast cancer survivors (n=183) living in metropolitan and non-metropolitan areas completed survey measures of PA, exercise preferences, attitudes, self-efficacy, perceived behavioral control (PBC), and intention toward PA. RESULTS: A structural equation model with adequate fit and quality ind…

MaleUrban PopulationPsychological interventionPsycho-oncologyExperimental and Cognitive PsychologyIntentionStructural equation modeling03 medical and health sciences0302 clinical medicineBreast cancerCancer SurvivorsSurveys and QuestionnairesPsychological TheorymedicineHumans030212 general & internal medicineExerciseAgedSelf-efficacyAustraliaMiddle Agedmedicine.diseaseSelf EfficacyPsychiatry and Mental healthOncology030220 oncology & carcinogenesisBehavioral medicineExercise intensityFemalePsychologyClinical psychologyPsycho-oncologyREFERENCES
researchProduct

The effects of a physical and cognitive training intervention vs. physical training alone on older adults' physical activity : A randomized controlle…

2021

BackgroundExecutive functions underlie self-regulation and are thus important for physical activity and adaptation to new situations. The aim was to investigate, if yearlong physical and cognitive training (PTCT) had greater effects on physical activity among older adults than physical training (PT) alone, and if executive functions predicted physical activity at baseline, after six (6m) and twelve months (12m) of the interventions, one-year post-intervention follow-up and an extended follow-up during COVID-19 lockdown.MethodsData from a single-blinded, parallel-group randomized controlled trial (PASSWORD-study, ISRCTN52388040) were utilized. Participants were 70-85 years old community-dwel…

MaleViral DiseasesPhysiologyEpidemiologySocial SciencesWalkingExecutive FunctionMedical ConditionsElderlyMedicine and Health SciencesPROGRAMPsychologyPublic and Occupational HealthSingle-Blind MethodGerontologi medicinsk/hälsovetenskaplig inriktningApplied PsychologyVirus TestingAged 80 and overkuntoliikuntaQEXECUTIVE FUNCTIONSRPublic Health Global Health Social Medicine and EpidemiologyinterventiotutkimusSports ScienceMultidisciplinary SciencesInfectious DiseasesTreatment OutcomeMedicineScience & Technology - Other TopicsFemaleikääntyneetfyysinen aktiivisuusResearch Articletoiminnanohjaus (psykologia)harjoitteetGeneral Science & TechnologyScienceEXERCISEADHERENCEAGEDiagnostic MedicinePEOPLEAdultsHumansGerontology specialising in Medical and Health SciencesSports and Exercise MedicinePandemicsAgedBehaviorScience & TechnologyTrail Making TestBiological LocomotionSARS-CoV-2DISABILITYKlinisk medicinBiology and Life SciencesCOVID-19Covid 19Physical ActivityPERFORMANCETillämpad psykologiEFFICACYLIFEFolkhälsovetenskap global hälsa socialmedicin och epidemiologiLogistic ModelsAge GroupsPhysical FitnessPeople and PlacesPopulation GroupingsClinical MedicineFollow-Up Studies
researchProduct

Etanercept treatment for extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis, or psoriatic arthritis : 6-year efficac…

2019

Background To describe the 6-year safety and efficacy of etanercept (ETN) in children with extended oligoarticular juvenile idiopathic arthritis (eoJIA), enthesitis-related arthritis (ERA), and psoriatic arthritis (PsA) Methods Patients who completed the 2-year, open-label, phase III CLinical Study In Pediatric Patients of Etanercept for Treatment of ERA, PsA, and Extended Oligoarthritis (CLIPPER) were allowed to enroll in its 8-year long-term extension (CLIPPER2). Children received ETN at a once-weekly dose of 0.8 mg/kg, up to a maximum dose of 50 mg/week. Efficacy assessments included the JIA core set of outcomes, the JIA American College of Rheumatology response criteria (JIA-ACR), and t…

Malelcsh:Diseases of the musculoskeletal systemArthritisCHILDRENCATEGORIESDISEASE-ACTIVITYEtanerceptEtanerceptEnthesitis-related arthritis (ERA)Juvenile Arthritis Disease Activity ScoreDOUBLE-BLINDINITIATIONNECROSIS-FACTORDEFINING CRITERIAMedicine and Health SciencesMedicineChildNon-U.S. Gov'tClinical trial; Efficacy; Enthesitis-related arthritis; Enthesitis-related arthritis (ERA); Etanercept; Extended oligoarticular juvenile idiopathic arthritis (eoJIA); Juvenile idiopathic arthritis; Psoriatic arthritis (PsA); SafetyOligoarthritisResearch Support Non-U.S. Gov'tMETHOTREXATEClinical trialTreatment OutcomeAntirheumatic AgentsChild PreschoolFemaleSafetymedicine.drugResearch Articlemedicine.medical_specialtyAdolescentEfficacyEnthesitis-related arthritisResearch SupportPsoriatic arthritisPsoriatic arthritis (PsA)Internal medicineAdalimumabJournal ArticleHumansetanercept ; juvenile idiopathic arthritis ; enthesitis-related arthritis ; extended oligoarticular juvenile idiopathic arthritis (eoJIA) ; enthesitis-related arthritis (ERA) ; psoriatic arthritis (PsA) ; efficacy ; safety ; clinical trialPEDIATRIC-PATIENTSbusiness.industryJuvenile idiopathic arthritismedicine.diseaseRheumatologyArthritis JuvenileOligoarticular Juvenile Idiopathic Arthritislcsh:RC925-935Extended oligoarticular juvenile idiopathic arthritis (eoJIA)businessADALIMUMAB
researchProduct

Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: A randomi…

2014

AbstractGuanfacine extended-release (GXR), a selective α2A-adrenergic agonist, is a non-stimulant treatment for attention-deficit/hyperactivity disorder (ADHD). This study assessed the efficacy (symptoms and function) and safety of dose-optimized GXR compared with placebo in children and adolescents with ADHD. An atomoxetine (ATX) arm was included to provide reference data against placebo. Patients (6–17 years) were randomized at baseline to dose-optimized GXR (0.05–0.12mg/kg/day – 6–12 years: 1–4mg/day; 13–17 years: 1–7mg/day), ATX (10–100mg/day) or placebo for 4 or 7 weeks. The primary efficacy measure was change from baseline in ADHD Rating Scale version IV (ADHD-RS-IV). Key secondary me…

Malemedicine.medical_specialtyAdolescentClinical NeurologyAtomoxetine HydrochloridePlaceboDouble-Blind MethodRating scaleInternal medicineAdrenergic alpha-2 Receptor AgonistsmedicineHumansAttention deficit hyperactivity disorderPharmacology (medical)FunctionGuanfacine HydrochlorideChildAdverse effectBiological PsychiatryPsychiatric Status Rating ScalesPharmacologyAdrenergic Uptake InhibitorsDose-Response Relationship DrugPropylaminesAtomoxetinemedicine.diseaseGuanfacineGuanfacinePsychiatry and Mental healthAttention-deficit/hyperactivity disorderNeurologyTreatment efficacyAttention Deficit Disorder with HyperactivityDelayed-Action PreparationsAnesthesiaFemaleNeurology (clinical)Safetymedicine.symptomPsychologySomnolencemedicine.drugEuropean Neuropsychopharmacology
researchProduct

Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study.

2015

Background Extended-release guanfacine hydrochloride (GXR), a selective α2A-adrenergic agonist, is a nonstimulant medication for attention-deficit/hyperactivity disorder (ADHD). This phase 3, double-blind, placebo-controlled, randomised-withdrawal study evaluated the long-term maintenance of GXR efficacy in children/adolescents with ADHD. Methods Children/adolescents (6–17 years) with ADHD received open-label GXR (1–7 mg/day). After 13 weeks, responders were randomised to GXR or placebo in the 26-week, double-blind, randomised-withdrawal phase (RWP). The primary endpoint was the percentage of treatment failure (≥50% increase in ADHD Rating Scale version IV total score and ≥2-point increase …

Malemedicine.medical_specialtyAdolescentPlacebo03 medical and health sciences0302 clinical medicineDouble-Blind MethodRating scaleInternal medicineOutcome Assessment Health CareDevelopmental and Educational PsychologymedicineClinical endpointAdrenergic alpha-2 Receptor AgonistsHumansTreatment FailureGuanfacine HydrochloridePsychiatryTrial registrationChildTime to treatment failure030227 psychiatryGuanfacinePsychiatry and Mental healthAttention Deficit Disorder with HyperactivityDelayed-Action PreparationsPediatrics Perinatology and Child HealthFemaleExtended releasePsychology030217 neurology & neurosurgeryEfficacy StudyJournal of child psychology and psychiatry, and allied disciplines
researchProduct